BP
BridgeBio Pharma, Inc. - Common Stock
BBIO
Close · 12/11/2026
78.17
1D
-1.72%52-week range
62.5 – 93.415
Volume
18,04,100.00
Price history
BBIO
14/10/2026 to 12/11/2026
O 79.00 H 80.82 L 78.00
1W+5.25%
1M+20.37%
3M-2.12%
6M+12.22%
1Y+17.41%
3Y+165.97%
5Y+51.90%
MAX+55.25%
Fundamentals
as of 12/11/2026- Market cap
- $15.23B
- Shares out
- 194.80M
- P/E (forward)
- -286.46
- EPS (trailing)
- -2.90
- Dividend yield
- 0.00%
- Beta
- 0.94
- Profit margin
- -59.84%
- P/B
- -5.89
SEC financial statements
25 quarterly and 9 annual periods through 30/09/2026.
Details
- Ticker
- BBIO
- Index
- -
- Sector
- -
- Industry
- -
- HQ
- -
Last close 12/11/2026.
Tracked by Congress
1 filer · 0 on watchlist · 9 buys · 1 sell · D: 10
- 02/11/2026Gilbert CisnerosBuyBridgeBio Pharma, Inc. - Common Stock$1,001–$15,000
- 27/10/2026Gilbert CisnerosBuyBridgeBio Pharma, Inc. - Common Stock$1,001–$15,000
- 29/09/2026Gilbert CisnerosSell+BridgeBio Pharma, Inc. - Common Stock$1,001–$15,000
- 11/05/2026Gilbert CisnerosBuyBridgeBio Pharma, Inc. - Common Stock$1,001–$15,000
- 29/04/2026Gilbert CisnerosBuyBridgeBio Pharma, Inc. - Common Stock$1,001–$15,000
- 19/03/2026Gilbert CisnerosBuyBridgeBio Pharma, Inc. - Common Stock$1,001–$15,000
- 18/03/2026Gilbert CisnerosBuyBridgeBio Pharma, Inc. - Common Stock$1,001–$15,000
- 03/03/2026Gilbert CisnerosBuyBridgeBio Pharma, Inc. - Common Stock$1,001–$15,000